Medetomidine is a synthetic compound used as a surgical anesthetic and analgesic. It is normally found as its hydrochloride salt, medetomidine hydrochloride. Medetomidine is an intravenously available alpha-2 adrenergic agonist. The drug has been developed by Orion Pharma. In the United States, it is currently approved for its veterinary use in dogs and distributed by Pfizer Animal Health. In Canada, medetomidine is distributed by Novartis Animal Health. The marketed product is a racemic mixture of two stereoisomers from which dexmedetomidine is the main active isomer. It is grouped under the following drug class(es): Alpha-2 agonists. Its therapeutic use is listed as veterinary tranquilizers. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Medetomidina and Medetomidinum. Its PubChem CID is 68602.
Medetomidine
| CAS No | 86347-14-0 |
|---|---|
| Molecular Formula | C13H16N2 |
| Molecular Weight | 200.28 g/mol |
| Synonyms | 5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Medetomidine is a synthetic compound used as a surgical anesthetic and analgesic. It is normally found as its hydrochloride salt, medetomidine hydrochloride. Medetomidine is an intravenously available alpha-2 adrenergic agonist.
The listed CAS number is 86347-14-0.
The listed molecular formula is C13H16N2.
The listed molecular weight is 200.28 g/mol.
5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole.
The source lists Medetomidina and Medetomidinum.